Secondary Logo

Journal Logo

August 15th, 1996 - Volume 12 - Issue 5
pp: 433-530

Antiviral Efficacy and Toxicity of Ribavirin in Murine Acquired Immunodeficiency Syndrome Model

Harvie, Pierrot; Omar, Rabeea F.; Dusserre, Nathalie; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12(5):451-461, August 15th, 1996.


A Randomized Trial (ISS 901) of Switching to Didanosine Versus Continued Zidovudine after the Diagnosis of AIDS

Vella, Stefano; Floridia, Marco; Dally, Leonard G.; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12(5):462-469, August 15th, 1996.

Predictive Value for Survival of Soluble Tumor Necrosis Factor Receptors p55 and p75 During Zidovudine-Containing Treatment in Symptomatic Human Immunodeficiency Virus Type 1 Infection

Frissen, P. H. Jos; Weverling, Gerrit Jan; Endert, Erik; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12(5):482-488, August 15th, 1996.


Measuring HIV-1 Incidence in Northern Thailand: Prospective Cohort Results and Estimates Based on Early Diagnostic Tests

Beyrer, Chris; Brookmeyer, Ron; Natpratan, Chawalit; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12(5):495-499, August 15th, 1996.

Determinants of HIV Infection among Female Commercial Sex Workers in Northeastern Thailand: Results from a Longitudinal Study

Ungchusak, Kumnuan; Rehle, Thomas; Thammapornpilap, Piyanit; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12(5):500-507, August 15th, 1996.

Human T-Cell Lymphotropic Virus Type I Infection in Barbados: Results of a 20-Year Follow-Up Study

Rabkin, Charles S.; Corbin, David O. C.; Felton, Susanne; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12(5):519-522, August 15th, 1996.